Skip to product information
1 of 1

CJC-1295 + Ipamorelin | Growth Hormone Research

REFERENCE STANDARD

Manufactured & Fulfilled in Wyoming, USA
Identity Verified • HPLC Tested • Lot Tracked • Research Use Only
VELORA RESEARCH ADVANTAGES
Fresh Production Lots
QR Traceability
Domestic Fulfillment
Direct Manufacturer Support
Lot-Specific Documentation
COA Available

Manufactured for Researchers Who Refuse to Compromise

Velora Biolabs manufactures, lyophilizes, packages, and fulfills research materials directly from our Wyoming laboratory.

Every production lot is assigned unique batch documentation, QR traceability, and lot-specific verification to support consistency and reproducibility.

Unlike suppliers relying on aging inventory and third-party fulfillment, Velora maintains direct oversight from production through shipment.

Regular price
$109.00
Sale price
$109.00
Specification

Scientific Background

Coordinated Growth Hormone Secretagogue Research & Endocrine Signaling

Category:

Growth Hormone Research • Endocrine Signaling • Pituitary Physiology • Growth Hormone Secretagogue Biology

 

What Researchers Study

CJC-1295 + Ipamorelin is a dual-peptide research formulation developed for laboratory investigation of endogenous growth hormone regulation through complementary receptor pathways.

Researchers study this combination because each peptide targets a different component of growth hormone physiology.

CJC-1295 (No DAC) functions as a growth hormone-releasing hormone (GHRH) analog that stimulates GHRH receptors within the anterior pituitary, while Ipamorelin selectively activates the ghrelin (GHSR-1a) receptor to investigate growth hormone secretagogue signaling.

Together, these complementary mechanisms allow researchers to examine coordinated regulation of growth hormone release, endocrine signaling, and downstream physiological responses in laboratory and preclinical models.

Primary Biological Pathways Studied

Research involving CJC-1295 + Ipamorelin commonly investigates:

  • Growth hormone-releasing hormone (GHRH) receptor signaling
  • Growth hormone secretagogue receptor (GHSR-1a) activation
  • Pulsatile growth hormone secretion
  • Hypothalamic-pituitary endocrine signaling
  • IGF-1 axis regulation
  • Growth hormone feedback mechanisms
  • Endocrine circadian biology
  • Neuroendocrine regulation

Unlike direct growth-factor analogs, this formulation is studied for its effects on upstream endocrine regulation of growth hormone secretion.

Why This Formulation Is Studied

Growth hormone secretion is regulated through multiple interacting signaling systems rather than a single biological pathway.

Researchers investigate this dual-peptide formulation because it allows laboratory models to examine how GHRH receptor activation and ghrelin receptor signaling coordinate endogenous growth hormone release.

The combination is commonly used to:

  • Study complementary endocrine signaling pathways
  • Compare dual-pathway versus single-receptor stimulation
  • Investigate pulsatile growth hormone regulation
  • Examine downstream IGF-1 responses following endogenous GH release
  • Explore neuroendocrine communication between the hypothalamus and pituitary

This complementary signaling profile makes the formulation valuable for endocrine physiology, pituitary biology, and growth hormone research.

 

Research Areas of Interest

Growth Hormone Physiology

Researchers investigate how coordinated activation of GHRH and ghrelin receptor pathways influences endogenous growth hormone secretion and pulsatility.

Endocrine Signaling

Studies examine communication between the hypothalamus, pituitary gland, and downstream endocrine tissues involved in growth hormone regulation.

Neuroendocrine Biology

Current research explores receptor signaling, hormonal feedback loops, circadian influences, and endocrine coordination involved in growth hormone physiology.

 

Selected Scientific References

Müller et al., Endocrine Reviews — Physiology of growth hormone-releasing hormone and pituitary regulation

Smith et al., Physiological Reviews — Ghrelin receptor biology and growth hormone secretagogues

Giustina & Veldhuis, Endocrine Reviews — Regulation of growth hormone secretion and endocrine feedback mechanisms

(References provided for educational context and literature navigation.)

 

Product Specifications

Compound Name: CJC-1295 (No DAC) + Ipamorelin

Composition:

  • CJC-1295 (No DAC): 5 mg
  • Ipamorelin: 10 mg

Form: Lyophilized powder

Appearance: White to off-white solid

Purity: ≥98% (HPLC verified)

Storage: ≤ –20 °C, desiccated, protected from light

 

Batch Documentation & Traceability

Each vial is shipped with a lot-specific QR code that provides secure access to batch documentation, including:

  • Certificate of Analysis (COA)
  • Identity verification report (HPLC / MS)
  • Lot number, potency, and expiration

Documentation is locked to the specific batch shipped to ensure traceability, version control, and research reproducibility.

QR access is provided with the physical product and is not reused across lots.

 

Research Use Disclaimer

This product is supplied strictly for laboratory research and in-vitro or preclinical investigation.

Not for human or veterinary use.

Not for diagnostic, therapeutic, or consumptive applications.